TF and prostate cancer: One remarkable outcome of this analysis was that a significant fraction of glycoproteins identified as cell surface TF-antigen carriers in PC-3 and DU-145 cells (Figure 2A) are associated with stem cell phenotype or function, including prostate cancer stem-like cells.